A novel model of bone-metastatic prostate cancer in immunocompetent mice

Prostate

Volumn 69, Issue 15, 2009, Pages 1613-1623

  Power, Carl A ^a,b   Pwint, Hnin ^a   Chan, Jeffrey ^a   Cho, Jae ^a   Yu, Yan ^a,b   Walsh, William ^a,b   Russell, Pamela J ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Animal models; Bone metastasis; Epithelial to mesenchymal transition; Osteolytic osteoblastic; Prostate cancer

Indexed keywords

AGAR; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METASTASIS; C57BL 6 MOUSE; CANCER CELL CULTURE; CANCER INVASION; CANCER MODEL; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOCOMPETENCE; IN VITRO STUDY; MALE; METASTASIS POTENTIAL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SOFT TISSUE; TUMOR LOCALIZATION;

ACID PHOSPHATASE; ANIMALS; BONE NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; IMMUNOCOMPETENCE; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; OSTEOCALCIN; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349504369     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21010     Document Type: Article

References (33)

1. Mundy G. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-593. (Pubitemid 37328925)
2. Callander NS, Roodman GD. Myeloma bone disease. Semin Hematol 2001;38(3):276-285.
3. Noguchi M, Kikuchi H, Ishibashi M, Noda S. Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer. Br J Cancer 2003;88(2):195-201. (Pubitemid 36255835)
4. Ohmori K, Matsui H, Yasuda T, Kanamori M, Yudoh K, Seto H, Tsuji H. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams. Jpn J Clin Oncol 1997;27(4):263-267. (Pubitemid 127516777)
5. Roodman G. Mechanisms of bone metastasis. N Engl J Med 2004;350(16):1655-1664.
6. Yi B, Williams P, Niewolna M, Wang Y, Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 2002;62:917-923. (Pubitemid 34126973)
7. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77(6):887-894. (Pubitemid 28378138)
8. Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, Chung LW, Zhau HE. Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 2006;66(15):1664-1673. (Pubitemid 44646357)
9. Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ, Chung LW. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 1996;93(26):15152-15157. (Pubitemid 27009568)
10. Holleran JL, Miller CJ, Edgehouse NL, Pretlow TP, Culp LA. Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells. Clin Exp Metastasis 2002;19(1):17-24.
11. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells. Prostate 2002;52(1):20-33. (Pubitemid 34553189)
12. Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res 2005;7(4):R444-R454.
13. Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M, Lowik CW, Gautschi E, Thalmann GN, Cecchini MG. Optical imaging of cancer metastasis to bone marrow: A mouse model of minimal residual disease. Am J Pathol 2002;160(3):1143-1153. (Pubitemid 34224600)
14. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001;16(8):1486-1495. (Pubitemid 32675200)
15. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999;25(3):255-259. (Pubitemid 29406050)
16. Nanes MS. Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1-15. (Pubitemid 37421390)
17. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003;3(11):807-821. (Pubitemid 37376979)
18. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000;408(6812):600-605.
19. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000;96(5):1873-1878. (Pubitemid 30661073)
20. Rho J, Takami M, Choi Y. Osteoimmunology: Interactions of the immune and skeletal systems. Mol Cells 2004;17(1):1-9. (Pubitemid 39137036)
21. Ruttinger D, Li R, Urba WJ, Fox BA, Hu HM. Evaluation of a preclinical model of bone metastasis for the study of adoptive immunotherapy. Eur Surg Res 2003;35(4):346-351. (Pubitemid 36736902)
22. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988;48(23):6876-6881. (Pubitemid 19012221)
23. Thompson T, Southgate J, Kitchener G. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted model. Cell 1989;5:917-930. (Pubitemid 19091004)
24. Baley PA, Yoshida K, Qian W, Sehgal I, Thompson TC. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer. J Steroid Biochem Mol Biol 1995;52(5):403-413.
25. McCabe NP, Madajka M, Vasanji A, Byzova TV. Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition. Clin Exp Metastasis 2008;25(5):581-590.
26. Rallis Z, Watkins G. Modified tetrachrome staining method for osteoid and defectively mineralized bone in paraffin sections. Biotech Histochem 1992;67(6):339-345. (Pubitemid 23018197)
27. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008;25(6):621-628.
28. Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996;156(3):217-226.
29. Birchmeier W, Birchmeier C. Epithelial-mesenchymal transitions in development and tumor progression. EXS 1995;74:1-15.
30. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007;39(3):305-318. (Pubitemid 46897605)
31. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 2005;24(50):7443-7454. (Pubitemid 41637984)
32. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003;63(9):2172-2178. (Pubitemid 36538623)
33. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Res 2006;66(23):11271-11278.